Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
Outpatients
Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
Outpatients
Emergency use authorization Experimental Antiviral Jan/23/2023
Sotrovimab
Outpatients
Emergency use authorization Experimental Antiviral Jul/14/2022
Bamlanivimab
Outpatients
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
Outpatients
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
REGEN-COV
Outpatients
Emergency use authorization Experimental Antiviral Jun/03/2022
Ivermectin
Outpatients
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Colchicine
Outpatients
Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022
Ritonavir
Outpatients
Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
Hydroxychloroquine sulfate
Outpatients
Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021
Lopinavir
Outpatients
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021